Table 6.
Mean (95% confidence limits) baseline and 12-month SAQ-CAN and SAQ, effect size (ES), standardized response means (SRM)
| PRO Domain | Baseline | 12-month | p value | ES | SRM |
|---|---|---|---|---|---|
| SAQ-CAN | |||||
| Indoor physical functioning | 75.57 (75.09–76.05) | 89.53 (89.09–89.97) | < 0.001 | 1.42 | 1.30 |
| Outdoor PHYSICAL FUNCTIONING | 52.29 (50.77–53.82) | 60.18 (58.83–61.53) | < 0.001 | 0.26 | 0.23 |
| Angina symptoms burden | 69.76 (68.77–70.74) | 81.03 (80.23–81.83) | < 0.001 | 0.59 | 0.53 |
| Treatment experience | 83.36 (82.41–84.31) | 86.38 (85.44–87.32) | < 0.001 | 0.15 | 0.15 |
| Original SAQ | |||||
| Physical limitation | 61.63 (60.67–62.58) | 67.35 (66.50–68.20) | < 0.001 | 0.30 | 0.28 |
| Angina stability | 71.24 (69.87–72.62) | 75.59 (74.31–76.87) | < 0.001 | 0.15 | 0.12 |
| Angina frequency | 78.73 (77.63–79.83) | 88.67 (87.85–89.48) | < 0.001 | 0.48 | 0.42 |
| Treatment satisfaction | 82.47 (81.71–83.23) | 85.82 (85.07–86.56) | < 0.001 | 0.21 | 0.29 |
| Disease perception | 61.78 (60.61–62.95) | 76.47 (75.52–77.42) | < 0.001 | 0.65 | 0.58 |